Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in Japan

Background. All-oral combination of direct-acting antivirals could lead to higher sustained virologic response (SVR) in hepatitis C virus (HCV)-infected patients. In the present study, we examined the efficacy and safety of the dual oral treatment with HCV nonstructural protein (NS) 5A inhibitor dac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Med Sci
Main Authors: Kanda, Tatsuo, Yasui, Shin, Nakamura, Masato, Suzuki, Eiichiro, Arai, Makoto, Haga, Yuki, Sasaki, Reina, Wu, Shuang, Nakamoto, Shingo, Imazeki, Fumio, Yokosuka, Osamu
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4893555/
https://ncbi.nlm.nih.gov/pubmed/27279790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.15519
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados